Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

High Expressions of Checkpoint Receptors in T Cells Subsets of Myelodysplastic Syndromes Patients with TP53 Mutations

Lingxu Jiang, Xin Huang, Xinping Zhou, Li Ye, Lu Wang, Chen Mei, Liya Ma, Gaixiang Xu, Chao Hu, Ziyang Zhou, Xiaozhen Liu, Yueyuan Han, Zheng Ge, Hongyan Tong

Blood (2023) 142 (Supplement 1): 4614.

https://doi.org/10.1182/blood-2023-182601

Published: 2023

Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Wei Wang, Shuanghong Zhu, Kongfei Li, Xinping Zhou, Liya Ma, Li Ye, Chen Mei, Lu Wang, Lingxu Jiang, Haitao Meng, Wen-Juan Yu, Jie Jin, Hongyan Tong, Jian Huang

Blood (2023) 142 (Supplement 1): 6481.

https://doi.org/10.1182/blood-2023-184789

Published: 2023

Journal Articles

EZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes

Qi Zhang, Wei Lang, Lu Wang, Wenli Yang, Yingwan Luo, Shuanghong Zhu, Lingxu Jiang, Yuxia Wang, Chen Mei, Xinping Zhou, Yanling Ren, Liya Ma, Li Ye, Xingnong Ye, Gaixiang Xu, Jie Sun, Jie Jin, Hongyan Tong

Blood (2022) 140 (Supplement 1): 9767–9768.

https://doi.org/10.1182/blood-2022-165886

Published: 2022

Journal Articles

The M6A Methyltransferase METTL14 Promotes Myelodysplastic Syndromes Development Via PI3K/Akt Signaling Pathway

Lingxu Jiang, Xinping Zhou, Chao Hu, Chen Mei, Gaixiang Xu, Liya Ma, Yanling Ren, Li Ye, Lu Wang, Yingwan Luo, Jie Jin, Jie Sun, Hongyan Tong

Blood (2022) 140 (Supplement 1): 6894–6895.

https://doi.org/10.1182/blood-2022-165203

Published: 2022

Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Shuanghong Zhu, Xinping Zhou, Kongfei Li, Lingxu Jiang, Hongyan Tong, Jie Jin

Blood (2022) 140 (Supplement 1): 9796–9797.

https://doi.org/10.1182/blood-2022-165344

Published: 2022

Journal Articles

Mutation Status and Burden Can Improve Prognostic Prediction of Patients with Lower-Risk Myelodysplastic Syndromes

Lingxu Jiang, Yingwan Luo, Jie Jin, MD PhD, Hongyan Tong

Blood (2019) 134 (Supplement_1): 3008.

https://doi.org/10.1182/blood-2019-125660

Published: 2019

NARROW

High Expressions of Checkpoint Receptors in T Cells Subsets of Myelodysplastic Syndromes Patients with TP53 Mutations

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

EZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes

The M6A Methyltransferase METTL14 Promotes Myelodysplastic Syndromes Development Via PI3K/Akt Signaling Pathway

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Mutation Status and Burden Can Improve Prognostic Prediction of Patients with Lower-Risk Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

High Expressions of Checkpoint Receptors in T Cells Subsets of Myelodysplastic Syndromes Patients with TP53 Mutations

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

EZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes

The M6A Methyltransferase METTL14 Promotes Myelodysplastic Syndromes Development Via PI3K/Akt Signaling Pathway

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Mutation Status and Burden Can Improve Prognostic Prediction of Patients with Lower-Risk Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only